Malaysian
Journal of Analytical Sciences Vol 24 No 6
(2020): 820 - 829
FIELD-AMPLIFIED SAMPLE INJECTION-CAPILLARY ZONE ELECTROPHORESIS METHOD
FOR THE ANALYSIS OF 5-FLUOROURACIL ANTICANCER DRUG
(Kaedah Suntikan Sampel Medan
Dipertingkat-Elektroforesis Zon Kapilari untuk Analisa Ubat Antikanser 5-Fluorouracil)
Nur Shahz Ereena Zulkifli1, Khairil Juhanni Abd Karim1,
Noorfatimah Yahaya3, Wan Aini Wan Ibrahim1, 2, Sazlinda
Kamaruzaman4, Nur Idayu Mat Ghani1, Aemi Syazwani Abdul
Keyon 1, 2*
1Department of
Chemistry, Faculty of Science
2Centre for Sustainable
Nanomaterials, Ibnu Sina Institute for Scientific and Industrial Research
Universiti Teknologi Malaysia, 81310 UTM,
Johor, Malaysia
3Integrative Medicine
Clusters, Advanced Medical and Dental Institute (AMDI),
Universiti Sains Malaysia, 13200 Kepala Batas,
Penang, Malaysia
4Department of
Chemistry, Faculty of Science,
Universiti Putra Malaysia, 43400 UPM Serdang,
Selangor, Malaysia
*Corresponding author: aemi@utm.my
Received: 20 July 2020;
Accepted: 11 September 2020; Published: 10 December 2020
Abstract
Field-amplified sample injection-capillary zone
electrophoresis (FASI-CZE) method was developed to enhance the detection
sensitivity of anticancer drug 5-fluorouracil (5-FU). The analyte was
introduced electrokinetically for 5 s into a capillary loaded with highly
conductive background electrolyte (BGE). The injected analyte migrated in
negative polarity, reducing separation time to 5 minutes as compared to
positive polarity in hydrodynamic injection-CZE (18 minutes). FASI-CZE was
optimized based on three parameters: Sample injection time (5 s, 10 s, and 40
s), BGE concentration in sample (3 mM, 5 mM, and 10 mM) and BGE concentration
(15 mM and 25 mM). Optimization of FASI-CZE was conducted to achieve optimal
conditions as followed: 15 mM borate BGE containing 0.1% w/v hexadimethrine
bromide (HDMB), 5-FU and 5-BrU (IS) prepared in 5 mM diluted BGE, 20% v/v
organic modifier in mixture sample was injected at -5 kV for 5 s. The
separation was conducted using -25 kV and detected at the wavelength of 234 nm
in diode array detection (DAD). The precision was reasonable; %RSD 4.43% at low
concentration levels (5 mg/L). The LOD value was 0.24 mg/L when applied with
FASI as compared to 0.58 mg/L using HDI-CZE. The sensitivity enhancement factor
(SEF) was almost 3 times higher than HDI-CZE at positive polarity, showing that
the proposed of FASI-CZE approach is appropriate for the study of 5-FU at trace
level.
Keywords: 5-fluorouracil,
field-amplified sample injection, capillary electrophoresis, anticancer drug
Abstrak
Kaedah suntikan sampel
medan dipertingkat-elektroforesis zon kapilari (FASI-CZE) dibangunkan untuk
pertama kalinya bagi meningkatkan kepekaan pengesanan ubat antikanser
5-fluorouracil (5-FU). Analit diperkenal secara elektrokinetik selama 5 s ke
dalam kapilari yang dimuatkan dengan elektrolit latar belakang yang sangat
konduktif (BGE). Analit yang disuntik berpindah dalam medan kutub negatif,
mengurangkan masa pemisahan kepada 5 minit berbanding dengan medan kutub
positif dalam suntikan hidrodinamik-CZE (18 minit). FASI-CZE dioptimumkan berdasarkan tiga parameter: masa
suntikan sampel (5s, 10s, dan 40s), kepekatan BGE dalam sampel (3 mM, 5 mM, dan
10 mM), dan kepekatan BGE (15 mM dan 25 mM). Pengoptimuman FASI-CZE dilakukan
untuk mencapai keadaan yang optimum. Keadaan optimum untuk FASI-CZE adalah
seperti berikut: 15 mM BGE borat yang mengandungi 0.1% w/v heksadimetrin
bromida (HDMB), 5-FU dan 5-BrU (IS) yang disiapkan dalam 5 mM BGE cair, 20% v/v
pengubah organik dalam campuran sampel disuntik pada voltan -5 kV selama 5 s.
Pemisahan dilakukan dengan menggunakan -25 kV voltan dan dikesan pada panjang
gelombang 234 nm dalam pengesanan susunan diod (DAD). Ketepatannya wajar; %RSD
4.43% pada tahap kepekatan rendah (5 mg/L). Nilai LOD adalah 0.24 mg/L ketika diterapkan
dengan FASI berbanding 0.58 mg/L menggunakan HDI-CZE. Faktor peningkatan
kepekaan (SEF) hampir 3 kali lebih tinggi daripada HDI-CZE pada medan
kutub positif, menunjukkan bahawa
pendekatan FASI-CZE yang dicadangkan sesuai untuk kajian 5-FU pada tahap
kepekatan surih.
Kata
kunci: 5-fluorouracil, suntikan
sampel medan dipertingkat, elektroforesis zon kapilari, elektroforesis
kapilari, ubat antikanser
References
1. Abdollahi, Z.,
Taheri-Kafrani, A., Bahrani, S. A. and Kajani, A. A. (2019). Pegaylated graphene
oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for
controlled delivery of methotrexate. Journal of Biotechnology, 298: 88-97.
2. National Cancer Institute
(2018). Chemotherapy and you. National Cancer Institute, U.S.: pp. 1-55.
3. Ali, I., Haque, A., Wani, W. A., Saleem, K.,
and Al Za'abi, M. (2013). Analyses of anticancer drugs by capillary
electrophoresis: A review. Biomedical Chromatography, 27(10):
1296-1311.
4. Usawanuwat, J., Boontanon,
N. and Boontanon, S. K. (2014). Analysis of three anticancer drugs
(5-fluorouracil, cyclophosphamide and hydroxyurea) in water samples by HPLC-MS/MS. International Journal of Advances in Agricultural
& Environmental Engineering, 1: 72-76.
5. Saif, M. W., Choma, A.,
Salamone, S. J. and Chu, E. (2009). Pharmacokinetically guided dose adjustment of
5-fluorouracil: A rational approach to improving therapeutic outcomes. JNCI: Journal of the National Cancer
Institute, 101(22): 1543-1552.
6. Kosjek, T. and Heath, E.
(2011). Occurrence, fate and determination of cytostatic pharmaceuticals in the
environment. TrAC Trends in Analytical Chemistry, 30(7):
1065-1087.
7. Cirillo, G., Iemma, F.,
Puoci, F., Parisi, O. I., Curcio, M., Spizzirri, U. G. and Picci, N. (2009).
Imprinted hydrophilic nanospheres as drug delivery systems for 5-fluorouracil
sustained release. Journal of Drug Targeting, 17(1): 72-77.
8. Zalewska, M., Wilk, K., and
Milnerowicz, H. (2013). Capillary electrophoresis application in the analysis of
the anti-cancer drugs impurities. Acta Poloniae Pharmaceutica, 70(2): 17180.
9. Sun, H., Wu, Y., He, P.,
Zuo, Y. and Lv, Y. (2012). Characterization of interaction between antitumor
drug 5-fluorouracil and human serum albumin by affinity capillary
electrophoresis. Asian Journal of Pharmaceutical Sciences, 7(1): 75-79.
10. Guichard, N., Guillarme, D.,
Bonnabry, P. and Fleury-Souverain, S. (2017). Antineoplastic drugs and their
analysis: A state of the art review. Analyst, 142(13):
2273-2321.
11. Forough, M., Farhadi, K.,
Molaei, R., Khalili, H., Shakeri, R., Zamani, A. and Matin, A. A. (2017).
Capillary electrophoresis with online stacking in combination with AgNPs@
MCM-41 reinforced hollow fiber solid-liquid phase microextraction for
quantitative analysis of capecitabine and its main metabolite 5-fluorouracil in
plasma samples isolated from cancer patients. Journal of Chromatography B, 1040: 22- 37.
12. Zhang, Z., Zhang, F. and
Liu, Y. (2013). Recent advances in enhancing the sensitivity and resolution of
capillary electrophoresis. Journal of Chromatographic Science, 51(7):
666-683.
13. Kitagawa, F. and Otsuka, K.
(2014). Recent applications of on-line sample preconcentration techniques in
capillary electrophoresis. Journal of Chromatography A, 1335: 43-60.
14. Xue, Y. and Yeung, E. S.
(1994). Characterization of band broadening in capillary electrophoresis due to
nonuniform capillary geometries. Analytical Chemistry, 66(21):
3575-3580.
15. Bruin, G. J. M., Stegeman,
G., Van Asten, A. C., Xu, X., Kraak, J. C. and Poppe, H. (1991). Optimization and
evaluation of the performance of arrangements for uv detection in
high-resolution separations using fused-silica capillaries. Journal of Chromatography A, 559(1-2):
163-181.
16. Chen, X., Tang, Y., Wang,
S., Song, Y., Tang, F. and Wu, X. (2015). Field‐amplified sample
injection in capillary electrophoresis with amperometric detection for the
ultratrace analysis of diastereomeric ephedrine alkaloids. Electrophoresis, 36(16):
1953-1961.
17. Rabanes, H. R., Aranas, A.
T., Benbow, N. L. and Quirino, J. P. (2012). Synergistic effect of field
enhanced sample injection on micelle to solvent stacking in capillary
electrophoresis. Journal of Chromatography A, 1267: 74-79.
18. Purrà, M., Cinca, R., Legaz,
J. and Núñez, O. (2014). Solid-phase extraction and field-amplified sample
injection–capillary zone electrophoresis for the analysis of benzophenone UV filters
in environmental water samples. Analytical and Bioanalytical Chemistry, 406(25):
6189-6202.
19. Hou, X., Deng, D., Wu, X.,
Lv, Y. and Zhang, J. (2010). Simultaneous stacking of cationic and anionic
compounds in single run capillary zone electrophoresis by two-end field
amplified sample injection. Journal of Chromatography A, 1217(35):
5622-5627.
20. Diasio, R. B. and Harris, B.
E. (1989). Clinical pharmacology of 5-fluorouracil. Clinical Pharmacokinetics, 16(4): 215-237.
21. Wielińska, J., Nowacki,
A. and Liberek, B. (2019). 5-fluorouracil—complete insight into its neutral and
ionised forms. Molecules, 24(20): 3683.
22. Breadmore, M. C. (2007).
Recent advances in enhancing the sensitivity of electrophoresis and
electrochromatography in capillaries and microchips. Electrophoresis, 28(1‐2):
254-281.
23. Prochazkova, A., Liu, S., Friess, H., Aebi, S., and Thormann,
W. (2001). Determination of 5-fluorouracil and
5-fluoro-2’-deoxyuridine-5’-monophosphate in pancreatic cancer cell line and
other biological materials using capillary electrophoresis. Journal of Chromatography A, 916:
215-224.
24. Flores, J. R., Nevado, J. J. B., Penalvo, G. C., and Caceres,
M. I. R. (2003). Direct capillary electrophoretic determination of three
chemotherapeutic drugs in human urine. Journal
of Chromatographia, 57: 493-496.
25. Lu, H.-j., Guo., Y.-l., Zhang, H. and Ou, Q.-y. (2003). Rapid
determination of 5-fluorouracil in plasma using capillary electrophoresis. Journal of Chromatography B, 788(2):
291-296.
26. Liu, Y., Zhu, P., Huang, Z., Zhou, Li. and Shi, P. (2018).
Simultaneous detection of 5-fluorocytosine and 5-fluorouracil in human cells
carrying CD/5-FC suicide gene system by using capillary zone electrophoresis. Journal of Chromatography B, 1076: 1-7.
27. Mahnik, S. N., Rizovski, B., Fuerhacker, M., and Mader, R. M.
(2004). Determination of 5-fluorouracil in hospital effluents. Analytical and Bioanalytical Chemistry,
380(1): 31-35.